000 | 01331 a2200373 4500 | ||
---|---|---|---|
005 | 20250512011303.0 | ||
264 | 0 | _c19900227 | |
008 | 199002s 0 0 eng d | ||
022 | _a0041-3879 | ||
024 | 7 |
_a10.1016/0041-3879(89)90055-x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHeap, B J | |
245 | 0 | 0 |
_aMycobacterium simiae as a cause of intra-abdominal disease: a case report. _h[electronic resource] |
260 |
_bTubercle _cSep 1989 |
||
300 |
_a217-21 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAbdomen |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAscitic Fluid _xmicrobiology |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsoniazid _xtherapeutic use |
650 | 0 | 4 |
_aKanamycin _xtherapeutic use |
650 | 0 | 4 |
_aMycobacterium _xpathogenicity |
650 | 0 | 4 |
_aMycobacterium Infections _xmicrobiology |
650 | 0 | 4 |
_aMycobacterium Infections, Nontuberculous _xdrug therapy |
650 | 0 | 4 |
_aNontuberculous Mycobacteria _xisolation & purification |
650 | 0 | 4 |
_aOfloxacin _xtherapeutic use |
650 | 0 | 4 |
_aPyrazinamide _xtherapeutic use |
650 | 0 | 4 |
_aRifampin _xtherapeutic use |
773 | 0 |
_tTubercle _gvol. 70 _gno. 3 _gp. 217-21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0041-3879(89)90055-x _zAvailable from publisher's website |
999 |
_c2623594 _d2623594 |